These differences in tumor mass with CIP4 KD may represent differing requirements of CIP4 in basal-like breast tumors (HCC 1806) and mesenchymal-like (MDA-MB-231) TNBC tumor subtypes. The gene discussed is TRIP10; the disease is neoplasm.